![Yves Decadt](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Yves Decadt
Chief Executive Officer at
POXEL
Profile
Yves Decadt is the founder of BioLingus (Cayman) Ltd., established in 2018, serving as Chairman & Chief Executive Officer.
Mr. Decadt is currently Chief Executive Officer & Director at Poxel SA, starting in 2026.
Former positions include Chief Executive Officer at Stragen Pharma SA, Chief Executive Officer at MEDIMETRICS Personalized Drug Delivery BV from 2015 to 2017, Director-Licensing & New Business Development at Johnson & Johnson and Johnson & Johnson AG from 2005 to 2010, and Vice President-Business Development at SkyePharma AG.
Education includes graduate degrees from Ghent University and Université Libre de Bruxelles.
Yves Decadt active positions
| Companies | Position | Start |
|---|---|---|
| POXEL | Chief Executive Officer | 09/06/2026 |
BioLingus (Cayman) Ltd.
 BioLingus (Cayman) Ltd. BiotechnologyHealth Technology Develops oral and mucosal delivery of peptides & proteins for chronic diseases | Chief Executive Officer | 07/08/2018 |
Former positions of Yves Decadt
| Companies | Position | End |
|---|---|---|
MEDIMETRICS Personalized Drug Delivery BV
 MEDIMETRICS Personalized Drug Delivery BV Drugstore ChainsRetail Trade Provides electronic oral drug delivery solutions | Chief Executive Officer | 31/05/2017 |
| JOHNSON & JOHNSON | Corporate Officer/Principal | 30/06/2010 |
Johnson & Johnson AG
 Johnson & Johnson AG Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Corporate Officer/Principal | 30/06/2010 |
SkyePharma AG | Corporate Officer/Principal | - |
Stragen Pharma SA
 Stragen Pharma SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and generic drugs | Chief Executive Officer | - |
Training of Yves Decadt
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
81
1st degree connections
9
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Johnson & Johnson
 Johnson & Johnson Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Poxel SA
 Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Ghent University
 Ghent University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Université Libre de Bruxelles
 Université Libre de Bruxelles Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
SkyePharma AG | |
Johnson & Johnson AG
Johnson & Johnson AG Pharmaceuticals: MajorHealth Technology Operates as an investment holding company with interests in health care products | Health Technology |
Stragen Pharma SA
Stragen Pharma SA Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals and generic drugs | Health Technology |
MEDIMETRICS Personalized Drug Delivery BV
MEDIMETRICS Personalized Drug Delivery BV Drugstore ChainsRetail Trade Provides electronic oral drug delivery solutions | Retail Trade |
BioLingus (Cayman) Ltd.
BioLingus (Cayman) Ltd. BiotechnologyHealth Technology Develops oral and mucosal delivery of peptides & proteins for chronic diseases | Health Technology |
- Stock Market
- Insiders
- Yves Decadt
